# Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)

> clinical trial · VERIFIED · 2026-07-07

Status: ACTIVE_NOT_RECRUITING · Sponsor: Genmab · Condition: Diffuse Large B Cell Lymphoma

- Company: Genmab
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04542824

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.